A detailed history of American Trust transactions in Natera, Inc. stock. As of the latest transaction made, American Trust holds 3,003 shares of NTRA stock, worth $481,260. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,003
Previous 3,208 6.39%
Holding current value
$481,260
Previous $347,000 9.8%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 29, 2024

SELL
$97.75 - $129.67 $20,038 - $26,582
-205 Reduced 6.39%
3,003 $381,000
Q2 2024

Sep 11, 2024

SELL
$85.28 - $112.6 $18,591 - $24,546
-218 Reduced 6.36%
3,208 $347,000
Q1 2024

Jun 11, 2024

BUY
$59.21 - $92.9 $1,894 - $2,972
32 Added 0.94%
3,426 $313,000
Q4 2023

Feb 21, 2024

BUY
$37.55 - $62.64 $127,444 - $212,600
3,394 New
3,394 $212,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track American Trust Portfolio

Follow American Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.